EB-1ABiotech and pharmaIndividualDecided July 2026Dismissed
Outcome: Dismissed
JUL092026_01B2203
Scholarly articlesMetOriginal contributionsNot metFinal meritsNot met
Our summary
Pharmaceutical researcher claiming EB-1A extraordinary ability asserts evidence of major contributions through highly cited publications on colorectal cancer treatment. AAO held petitioner met only two of three claimed criteria; publications in respected journals do not automatically demonstrate major significance; no evidence of substantial field impact; appeal dismissed.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
What the AAO accepted
- Scholarly articles · Petitioner met criterion based on published work; however, criterion alone insufficient for final merits determination.
What was missing
- Original contributions · Publications in high-impact journals alone insufficient; petitioner did not demonstrate contributions were of major significance or spurred widespread field commentary.
- Final merits · Only two of three claimed criteria actually met; extraordinary ability not established; prospective potential impact insufficient for current major significance.
Criteria
| Criterion | Reading | Why |
|---|---|---|
 Scholarly articles | Met | Petitioner met criterion based on published work; however, criterion alone insufficient for final merits determination. |
 Original contributions | Not met | Publications in high-impact journals alone insufficient; petitioner did not demonstrate contributions were of major significance or spurred widespread field commentary. |
 Final merits | Not met | Only two of three claimed criteria actually met; extraordinary ability not established; prospective potential impact insufficient for current major significance. |
A published decision describes one case. It is not legal advice and not a prediction for yours.